Transient Production of scFv-Fc Fusion Proteins in Mammalian Cells

  • Thomas SchirrmannEmail author
  • Konrad Büssow
Part of the Springer Protocols Handbooks book series (SPH)


Single chain Fv (scFv) antibody fragments fused to the human immunoglobulin G (IgG) Fc moiety obtain IgG-like properties, but nevertheless they are still encoded by a single gene. As transient production of scFv-Fc proteins in mammalians can easily achieve milligram amounts, this antibody format is particularly suitable for many research applications. Here, we describe two protocols for the transient secretory production of scFv-Fc antibodies in transformed adherent human embryonic kidney cells HEK293T and suspension HEK293-6E cells. More than 10 µg/mL yield of scFv-Fc protein can be obtained every day for one to two weeks by transient production in HEK293T cells, whereas soluble HEK293-6E cells produce more than 100 µg/mL scFv-Fc protein within 5 days under serum-free conditions.


HEK293T Cell Capture ELISA Human Embryonic Kidney Cell Line Transient Production Calcium Phosphate Transfection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM (2008) Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res 36:e96PubMedCrossRefGoogle Scholar
  2. Baker KN, Rendall MH, Hills AE, Hoare M, Freedman RB, James DC (2001) Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnol Bioeng 73:188–202PubMedCrossRefGoogle Scholar
  3. Baldi L, Hacker DL, Adam M, Wurm FM (2007) Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett 29:677–684PubMedCrossRefGoogle Scholar
  4. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297–7301PubMedCrossRefGoogle Scholar
  5. Boussif O, Zanta MA, Behr JP (1996) Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 3:1074–1080PubMedGoogle Scholar
  6. Durocher Y, Perret S, Kamen A (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30:E9PubMedCrossRefGoogle Scholar
  7. Durocher Y, Pham PL, St-Laurent G, Jacob D, Cass B, Chahal P, Lau CJ, Nalbantoglu J, Kamen A (2007) Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells. J Virol Methods 144:32–40PubMedCrossRefGoogle Scholar
  8. Geisse S, Henke M (2005) Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production. J Struct Funct Genomics 6:165–170PubMedCrossRefGoogle Scholar
  9. Godbey WT, Wu KK, Hirasaki GJ, Mikos AG (1999a) Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther 6:1380–1388PubMedCrossRefGoogle Scholar
  10. Godbey WT, Wu KK, Mikos AG (1999b) Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 45:268–275PubMedCrossRefGoogle Scholar
  11. Gramer MJ, Goochee CF, Chock VY, Brousseau DT, Sliwkowski MB (1995) Removal of sialic acid from a glycoprotein in CHO cell culture supernatant by action of an extracellular CHO cell sialidase. Biotechnology (NY) 13:692–698CrossRefGoogle Scholar
  12. Jones D, Kroos N, Anema R, van Montfort B, Vooys A, van der Kraats S, van der Helm E, Smits S, Schouten J, Brouwer K, Lagerwerf F, van Berkel P, Opstelten DJ, Logtenberg T, Bout A (2003) High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog 19:163–168PubMedCrossRefGoogle Scholar
  13. Jostock T, Vanhove M, Brepoels E, Van Gool R, Daukandt M, Wehnert A, Van Hegelsom R, Dransfield D, Sexton D, Devlin M, Ley A, Hoogenboom H, Mullberg J (2004) Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries. J Immunol Methods 289:65–80PubMedCrossRefGoogle Scholar
  14. Lifely MR, Hale C, Boyce S, Keen MJ, Phillips J (1995) Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. Glycobiology 5:813–822PubMedCrossRefGoogle Scholar
  15. Loignon M, Perret S, Kelly J, Boulais D, Cass B, Bisson L, Afkhamizarreh F, Durocher Y (2008) Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells. BMC Biotechnol 8:65PubMedCrossRefGoogle Scholar
  16. Meissner P, Pick H, Kulangara A, Chatellard P, Friedrich K, Wurm FM (2001) Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng 75:197–203PubMedCrossRefGoogle Scholar
  17. Menzel C, Schirrmann T, Konthur Z, Jostock T, Dübel S (2008) Human antibody RNase fusion protein targeting CD30+ lymphomas. Blood 111:3830–3837PubMedCrossRefGoogle Scholar
  18. Pham PL, Perret S, Cass B, Carpentier E, St-Laurent G, Bisson L, Kamen A, Durocher Y (2005) Transient gene expression in HEK293 cells: peptone addition posttransfection improves recombinant protein synthesis. Biotechnol Bioeng 90:332–344PubMedCrossRefGoogle Scholar
  19. Schirrmann T, Al-Halabi L, Dübel S, Hust M (2008) Production systems for recombinant antibodies. Front Biosci 13:4576–4594PubMedCrossRefGoogle Scholar
  20. Schlaeger EJ, Christensen K (1999) Transient gene expression in mammalian cells grown in serum-free suspension culture. Cytotechnology 30:71–83PubMedCrossRefGoogle Scholar
  21. Thomas M, Klibanov AM (2003) Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 62:27–34PubMedCrossRefGoogle Scholar
  22. Umana P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE (1999) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 17:176–180PubMedCrossRefGoogle Scholar
  23. Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393–1398PubMedCrossRefGoogle Scholar
  24. Wurm F, Bernard A (1999) Large-scale transient expression in mammalian cells for recombinant protein production. Curr Opin Biotechnol 10:156–159PubMedCrossRefGoogle Scholar
  25. Zhang XQ, Tang H, Hoshi R, De Laporte L, Qiu H, Xu X, Shea LD, Ameer GA (2009) Sustained transgene expression via citric acid-based polyester elastomers. Biomaterials 30:2632–2641PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Technische Universität BraunschweigInstitut für Biochemie und Biotechnologie, Department of BiotechnologyBraunschweigGermany
  2. 2.Department of Structural BiologyHelmholtz Centre for Infection ResearchBraunschweigGermany

Personalised recommendations